Gabriel G. L.
- Country
- Spain
- Department
- Allergy
Research Overview
Data & Insights
Has run more than one trial at 0 of 55 partner sites.
Specializations
Allergic Respiratory Disorders
The investigator concentrates on Allergic rhinitis and asthma driven by common aero‑allergens such as dust mite, grass pollen and olive pollen, aiming to improve diagnostic precision and therapeutic outcomes.
- Dust mite induced rhinitis
- Grass pollen allergy management
- Olive pollen sensitization studies
- Severe asthma phenotyping
Clinical activities are conducted at Hospital Universitario De Navarra, Pamplona, Spain.
Atopic Dermatitis and Skin Allergy
Research addresses chronic inflammatory skin conditions including Atopic dermatitis, eczema, and various forms of urticaria such as chronic spontaneous urticaria and cold‑induced urticaria, with a focus on disease severity and patient‑centered treatment strategies.
- Severe AD biologic therapy
- Urticaria phenotype classification
- Biomarker development for eczema
- Quality‑of‑life assessment in skin allergy
The work integrates dermatology and allergy expertise within the same clinical setting.
Food and Environmental Allergy
Investigations target IgE‑mediated food allergy and broader environmental allergen sensitization, exploring mechanisms of tolerance and novel immunotherapeutic approaches.
- Oral immunotherapy protocols
- Component‑resolved diagnostics
- Cross‑reactivity mapping
- Preventive strategies in pediatric populations
Findings support evidence‑based dietary guidance and environmental control measures.
Systemic Autoimmune and Immune‑Mediated Diseases
Beyond classical allergy, the investigator engages in translational work on Systemic lupus erythematosus, its renal manifestation lupus nephritis, and ANCA‑associated vasculitis, emphasizing immune dysregulation and targeted interventions.
- B‑cell depletion strategies in SLE
- Renal biomarker discovery for lupus nephritis
- Vasculitis activity monitoring
- Integration of immunogenetics in therapy selection
Collaboration with rheumatology and nephrology units enhances multidisciplinary care.
Immunotherapy and Biologic Innovation
Focused on advancing biologic therapy and monoclonal antibodies for allergic and immune‑mediated conditions, the investigator evaluates anti‑IgE agents, IL‑4/IL‑13 blockade, and emerging cellular therapies.
- Anti‑IgE monoclonal development
- IL‑4Rα antagonist clinical evaluation
- CAR‑T cell approaches for refractory allergy
- Real‑world effectiveness of biologics
These efforts aim to translate cutting‑edge immunology into tangible patient benefits.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.